Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-21 4:30 pm Purchase | 13D | G1 Therapeutics Inc. GTHX | ESHELMAN FREDRIC N | 4,766,074 9.260% | 1,072,479 (+29.04%) | View |
2023-02-13 4:06 pm Purchase | 13D | EYENOVIA INC EYEN | ESHELMAN FREDRIC N | 1,708,548 4.700% | 17,108 (+1.01%) | View |
2022-04-05 4:15 pm Purchase | 13D | Aravive Inc. ARAV | ESHELMAN FREDRIC N | 10,111,882 34.000% | 5,806,201 (+134.85%) | View |
2022-01-05 6:32 pm Purchase | 13D | Aravive Inc. ARAV | ESHELMAN FREDRIC N | 4,305,681 19.990% | 472,828 (+12.34%) | View |
2021-02-18 7:00 pm Purchase | 13D | Aravive Inc. ARAV | ESHELMAN FREDRIC N | 3,832,853 19.800% | 2,901,755 (+311.65%) | View |
2020-08-28 4:34 pm Unchanged | 13D | EYENOVIA INC EYEN | ESHELMAN FREDRIC N | 1,691,440 6.800% | 0 (Unchanged) | View |
2020-08-14 4:37 pm Purchase | 13D | EYENOVIA INC EYEN | ESHELMAN FREDRIC N | 1,691,440 8.200% | 17,095 (+1.02%) | View |
2020-04-15 7:56 pm Purchase | 13D | Aravive Inc. ARAV | ESHELMAN FREDRIC N | 931,098 5.800% | 931,098 (New Position) | View |